These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


394 related items for PubMed ID: 20417473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
    Michiels JJ, van Vliet HH, Berneman Z, Schroyens W, Gadisseur A.
    Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
    [Abstract] [Full Text] [Related]

  • 5. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA.
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Von Willebrand disease: pathogenesis and management.
    Rodeghiero F.
    Thromb Res; 2013 Jan; 131 Suppl 1():S47-50. PubMed ID: 23452742
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Jan; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 10. [Inborn and acquired von Willebrand disease].
    Schneppenheim R, Budde U.
    Hamostaseologie; 2008 Dec; 28(5):312-9. PubMed ID: 19132162
    [Abstract] [Full Text] [Related]

  • 11. New approach of the treatment of von Willebrand's disease during pregnancy.
    Gojnic M, Fazlagic A, Likic I, Stefanovic A, Vidakovic S, Pervulov M, Petkovic S, Mostic T, Miljic P, Bogdanovic A.
    Arch Gynecol Obstet; 2005 Nov; 273(1):35-8. PubMed ID: 16172853
    [Abstract] [Full Text] [Related]

  • 12. Prophylaxis in von Willebrand disease.
    Franchini M, Targher G, Lippi G.
    Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944
    [Abstract] [Full Text] [Related]

  • 13. Treatment of von Willebrand's Disease.
    Mannucci PM.
    N Engl J Med; 2004 Aug 12; 351(7):683-94. PubMed ID: 15306670
    [No Abstract] [Full Text] [Related]

  • 14. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.
    Castaman G, Federici AB, Rodeghiero F, Mannucci PM.
    Haematologica; 2003 Jan 12; 88(1):94-108. PubMed ID: 12551832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB.
    Curr Hematol Rep; 2003 Sep 12; 2(5):373-80. PubMed ID: 12932308
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.